stars 1 stars 2 stars 3

We develop and manufacture scalable bioprocess technologies for the biotechnology and pharmaceutical industries, supporting both Multi-Use and Single-Use strategies. Our portfolio includes bioreactors, tangential flow filtration (TFF) systems, software for process control and monitoring, cell and gene therapy platforms, modular systems, and single-use consumables such as bags and flowkits. Our solutions are designed to facilitate efficient scale-up from laboratory to pilot and commercial production, ensuring robust performance, automation, and adaptability across a wide range of applications from monoclonal antibodies and vaccines to cell therapies, recombinant proteins, enzymes, microbial fermentation, and more.

TECNIC Questions

The TECNIC annual revenue was $7.9 million in 2026.

Manel Cudinach is the Founder and CEO of TECNIC.

37 people are employed at TECNIC.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users